PTCT
Conviction 20HealthcareScan · Thu, Sep 24, 2026Ptc Therapeutics, Inc. (PTCT) closed at $62.29 (-0.08%) on Sep 24, 2026. Its latest daily candle is a hammer. Price is below its 50-day and below its 200-day moving average. RSI(14) 31, RS Rating 30, -30.4% from its 52-week high, -18.8% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- PTC Completes Acquisition of ST-920 Fabry Disease Gene TherapyPR Newswire · Mon, Sep 21, 2026
- PTC THERAPEUTICS, INC.: Material event (8-K)SEC EDGAR · Mon, Sep 21, 2026
Congress activity
Disclosed STOCK Act trades in PTCT
Insider activity
SEC Form 4 transactions in PTCT · open-market 10 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
SCHMERTZLER MICHAEL Director · Common Stock · 2026-09-10 | Sell | 10K | $673K | 2026-09-10 | 2026-09-11 |
SCHMERTZLER MICHAEL Director · Common Stock · 2026-09-09 | Sell | 9.43K | $639K | 2026-09-09 | 2026-09-11 |
SCHMERTZLER MICHAEL Director · Common Stock · 2026-09-09 | Sell | 572 | $39K | 2026-09-09 | 2026-09-11 |
SCHMERTZLER MICHAEL Director · Common Stock · 2026-08-27 | Sell | 610 | $44K | 2026-08-27 | 2026-08-28 |
SCHMERTZLER MICHAEL Director · Common Stock · 2026-08-27 | Sell | 11.89K | $851K | 2026-08-27 | 2026-08-28 |
SCHMERTZLER MICHAEL Director · Common Stock · 2026-08-26 | Sell | 6.87K | $500K | 2026-08-26 | 2026-08-28 |
SCHMERTZLER MICHAEL Director · Common Stock · 2026-08-26 | Sell | 5.63K | $412K | 2026-08-26 | 2026-08-28 |
SCHMERTZLER MICHAEL Director · Common Stock · 2026-08-20 | Sell | 2.39K | $172K | 2026-08-20 | 2026-08-21 |
SCHMERTZLER MICHAEL Director · Common Stock · 2026-08-20 | Sell | 691 | $50K | 2026-08-20 | 2026-08-21 |
SCHMERTZLER MICHAEL Director · Common Stock · 2026-08-20 | Sell | 9.42K | $667K | 2026-08-20 | 2026-08-21 |
SEC filings
EDGAR filings in PTCT · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.